Nasal spray for dust mite allergy study
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new nasal spray for people with dust mite allergies that cause year-round nasal symptoms. It aims to see if the spray safely relieves symptoms like stuffy nose and sneezing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have had dust mite allergy symptoms (like a runny or stuffy nose) for more than one year.
- If you have asthma, it must be well-controlled with no recent severe attacks.
- You can stop taking allergy pills (antihistamines) for 1 week and nasal steroid sprays for 1 month before the study starts.
- You do not have any other year-round allergies or seasonal allergies that are currently active.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests allergy drops placed under the tongue to treat allergic rhinitis caused by house dust mites. It aims to see if the drops can safely reduce symptoms like sneezing and stuffy nose.
This trial tests a spray placed under the tongue to treat allergic rhinitis caused by dust mites, pet dander, or mold. It looks at how the spray affects the bacteria in your nose and body.
This trial tests a dust-mite allergy extract (“allergy shots”) to see if it safely reduces symptoms from dust-mite–driven hay fever (rhinitis/rhinoconjunctivitis), and possibly asthma symptoms. If you qualify, it may help your immune system tolerate dust mites better over time.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.
This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.
Hear when a new Allergic Disorder of Respiratory System trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.